Changes of gut microbiota and short chain fatty acids in patients with Peutz-Jeghers syndrome

An Zhou1, Bo Tang1, Yuhong Xie2

  • 1Department of Gastroenterology, Second Affiliated Hospital, Army Medical University, Chongqing, 400037, China.

BMC Microbiology
|November 30, 2023
PubMed

Insights

Peutz-Jeghers Syndrome (PJS) patients exhibit gut microbiota dysbiosis and reduced short-chain fatty acids. Gut bacteria like Bacteroides and Agathobacter correlate with PJS severity and onset, aiding future PJS diagnosis.

Area of Science:

  • Gastroenterology
  • Microbiome Research
  • Genetics

Background:

  • Peutz-Jeghers Syndrome (PJS) is a rare genetic disorder linked to gastrointestinal polyps and pigmentation.
  • The role of gut microbiota in PJS pathogenesis and progression is largely unexplored.
  • STK11 gene mutations are implicated in PJS, but effective treatments are lacking.

Purpose of the Study:

  • To investigate the gut microbiota composition and short-chain fatty acid (SCFA) levels in PJS patients.
  • To explore correlations between gut microbiota, SCFA levels, and clinical parameters in PJS.
  • To compare gut microbiota between STK11-positive and STK11-negative PJS patients.

Main Methods:

  • 16S rRNA sequencing was employed to analyze the gut microbiota of 79 PJS patients.
  • Intestinal short-chain fatty acid levels were quantified.
  • A random forest model was developed based on microbial data for potential PJS prediction.

Main Results:

  • Significant gut microbiota dysbiosis and decreased SCFA synthesis were observed in PJS patients.
  • Bacteroides abundance correlated positively with maximum polyp length; Agathobacter correlated negatively with age of onset.
  • Acetic, propionic, and butyric acid levels showed correlations with age of onset, polyp number, and endoscopic surgery frequency. No significant microbial differences were found between STK11-positive and STK11-negative PJS patients.

Conclusions:

  • Gut microbiota alterations and reduced SCFAs are characteristic of PJS.
  • Specific bacterial taxa and SCFAs may serve as biomarkers for PJS clinical manifestations.
  • Microbiota-based models hold promise for future PJS diagnosis and targeted therapeutic strategies.

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
280
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
456
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
72.1K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
468